Home > Market Activity > Get Quotes > News > News Article

OrganiGram Holdings Inc

Exchange: TSXV Exchange | Mar 24, 2019, 10:25 PM EDT

$ 9.22 real time data Change Down
-0.17 (-1.81%)
Real-time price
Day Low 8.89
Day High 9.41

OrganiGram Holdings Inc. Announces Issuance of Stock Options

MONCTON, NEW BRUNSWICK--(Marketwired - June 28, 2016) - OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (the "Company") announces that it has issued an aggregate of 190,000 incentive stock options to various directors, officers and persons providing Investor Relations Activities as follows:

(a) 60,000 incentive stock options at an exercise price of $1.01 to Mr. Larry Rogers, a director of the Company and the Company's Chief Operating Officer; (b) 40,000 incentive stock options at an exercise price of $1.01 to Ms. Giselle Doiron, the Company's director of Investor and Media Relations; (c) 40,000 incentive stock options at an exercise price of $1.25 to Mr. Peter Amirault, the Company's newest director; and (d) 50,000 incentive stock options at an exercise price of $1.25 to Mr. Raymond Gracewood, the Company's Chief Commercial Officer.

These options have been granted pursuant to the Company's Stock Option Plan which has been previously approved by the Company's shareholders and the TSX Venture Exchange. In accordance with the Plan, all options expire 10 years after issuance and are subject to a 5 year vesting period.

About OrganiGram Holdings Inc.

OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.

On behalf of the Board of Directors, Denis Arsenault, Director and CEO, OrganiGram Holdings Inc.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

OrganiGram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986

Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia. See the QuoteMedia Terms of Use.